Structure of human cyclin-dependent kinase inhibitor p19(INK4d): Comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16(INK4a)

Structure

Volumn 6, Issue 10, 1998, Pages 1279-1290

  Baumgartner, Roland ^a   Fernandez Catalan, Carlos ^a   Winoto, Astar ^b   Huber, Robert ^a   Engh, Richard A ^a   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CDK4 inhibitor; Cell cycle; p19(INK4d) p16(INK4a); Structure

Indexed keywords

EID: 0032532157     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00128-2     Document Type: Article

References (42)

1. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
2. Hunter, T. & Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
3. Ruas, M. & Peters, G. (1998). BBA Reviews in Cancer, in press.
4. Serrano, M., Hannon, G.J. & Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
5. Kamb, A., et al., & Skolnick, M.H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
6. Miller, C.W., Yeon, C., Aslo, A., Mendoza, S., Aytac, U. & Koeffler, H.P. (1997). The p19(INK4d) cyclin dependent kinase gene is altered in osteosarcoma. Oncogene 15, 231-235.
7. Hirai, H., et al, & Sherr, C.J. (1995). Novel INK4 proteins, p19 and p 18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15, 2672-2682.
8. INK4/MTS1, p18 and p19 in human cancer cell lines. Int. J. Cancer 68, 605-611.
9. Bork, P. (1993). Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins 17, 363-374.
10. ink4a, Mol. Cell Biol. 15, 2682-2688.
11. INKd, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell 7, 57-70.
12. INK4 mutations. Nat Struct. Biol. 5, 74-81.
13. Ink4d, Nature 389, 999-1003.
14. INK4a: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1, 421-431.
15. INK4d, FEBS Lett. 401, 127-132.
16. Parker, M.H. & Hefford, M.A. (1997). A consensus residue analysis of loop and helix-capping residues in four-α-helical-bundle proteins. Protein Eng. 10, 487-496.
17. Aurora, R. & Rose, G.D. (1998). Helix capping. Protein Sci. 7, 21-38.
18. Blanco, F.J., Ortiz, A.R. & Serrano, L. (1997). Role of a nonnative interaction in the folding of the protein G B1 domain as inferred from conformational analysis of the α-helix fragment. Fold. Des. 2, 123-133.
19. INK4a: structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35, 9475-9487.
20. Yang, Y., Sambasivarao, N., Sen, S. & Qin, J. (1998). The structural basis of ankyrin-like repeat function as revealed by the solution structure of myotrophin. Structure 6, 619-626.
21. Svetlana, G. & Pavletich, N.P. (1996). Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of p53BP2. Science 274, 1001-1005.
22. Batchelor, A.H., Piper, D.E., de la Brousse, F.C., McKnight, S.L. & Wolberger, C. (1998). The structure of GABPα/β: an ETS domainankyrin repeat heterodimer bound to DNA. Science 279, 1037-1041.
23. CDKN2/INK4A, Curr. Biol. 6, 84-91.
24. Fahraeus, R., Lain, S., Ball, K.L & Lane, D.P. (1998). Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumor suppressor molecule. Oncogene 16, 587-596.
25. CDKN2 associated with familial melanoma. Mol. Cell Biol. 16, 3844-3852.
26. INK4a tumor suppressor protein. Cancer Res. 55, 2503-2506.
27. INK4 proteins encoded by tumor-derived alleles.J. Biol. Chem. 271, 28734-28737.
28. Reymond, A. & Brent, R. (1995). p16 proteins from melanoma-prone families are deficient in binding to CDK6. Oncogene 11, 1173-1178.
29. INK4a. Nat. Struct. Biol. 5, 85-88.
30. INK4 function. Nat. Genet 10, 114-116.
31. INK4a/CDKN2Ain human glioma. Oncogene 14, 603-609.
32. INK4a and its interaction with CDK4. Biochem. Biophys. Res. Commun. 218, 254-258.
33. Otwinowski, Z. (1991). Isomorphous Replacement and Anomalous Scattering, Proceedings of the Daresbury Study Weekend. SERC Daresbury Laboratory, Warrington, UK.
34. Collaborative Computing Project No. 4. (1994). The CCP4 suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
35. Knight, S. (1989). Ribulose 1,5-bisphosphate carboxylase/ oxygenase - a structural study. PhD thesis, Swedish University of Agricultural Science, Uppsala, Sweden.
36. Turk, D. (1992). Weiterentwicklung eines Programmes für Molekülgraphik und Elektronendichte-Manipulation und seine Anwendung auf verschiedene Protein-Strukturaufklärungen. University of Munich, Germany.
37. Brünger, AT. (1993). XPLOR Version 3.1 Manual. Yale University, New Haven, CT.
38. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. (1997). Refinement of macromolecular structures by the maximum likelihood method. Acta Cryst. D 53, 240-255.
39. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Cryst. A 50, 157-163.
40. Michaely, P. & Bennett, V. (1992). The ANK repeat: a ubiquitous motif involved in macromolecular recognition. Trends Cell Biol. 2, 127-130.
41. Roussel, A. & Cambilleau, C. (1989). TURBO-FRODO in silicon graphics geometry, partners directory (Silicon Graphics, Mountain View, CA).
42. Nicholls, A., Bharadwaj, R. & Honig, B. (1993). GRASP - graphical representation and analysis of surface properties. Biophys. J. 64, 166-169.